Aerovate Therapeutics, Inc.(AVTE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AVTE Aerovate Therapeutics, Inc.

Closed 04-28 16:00:00 EDT

2.68

+0.00

0.00%

High2.68	Low2.68	Vol0.00
Open2.68	D1 Closing2.68	Amplitude0.00%
Mkt Cap77.68M	Tradable Cap32.06M	Total Shares28.99M
T/O2.77M	T/O Rate0.00%	Tradable Shares11.96M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AVTE","market":"US","secType":"STK","nameCN":"Aerovate Therapeutics, Inc.","latestPrice":2.68,"timestamp":1745870400000,"preClose":2.68,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":11964465,"shares":28985019,"eps":-1.702457,"marketStatus":"Closed","change":0,"latestTime":"04-28 16:00:00 EDT","open":2.68,"high":2.68,"low":2.68,"amount":2768541.0360660003,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.702457,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784016000000},"marketStatusCode":5,"symbolChange":{"newSymbol":"JBIO","executeDate":"2025-04-29"},"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":2.68,"dividendRate":0.895522,"volumeRatio":0},"requestUrl":"/m/hq/s/AVTE","defaultTab":"news","newsList":[{"id":"2530840242","title":"Press Release: Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2530840242","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530840242?lang=en_us&edition=fundamental","pubTime":"2025-04-28 22:19","pubTimestamp":1745849940,"startTime":"0","endTime":"0","summary":"Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million. Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases. Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial data expected in first half of 2026. The combined company will operate as \"Jade Biosciences, Inc.\" and will trade on Nasdaq under the ticker symbol \"JBIO\". SAN FRANCISCO and VANCOUVER, British Columbia, April 28, 2025  -- Jade Biosciences, Inc. , a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the completion of its previously announced merger with Aerovate Therapeutics, Inc. . The combined company will operate as Jade Biosciences, Inc., with its shares expected to begin trading on the Nasdaq Capital Market on April 29, 2025, under the ticker symbol \"JBIO.\". Follow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4007","BK4539","AVTE","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2529081358","title":"BRIEF-Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2529081358","media":"Reuters","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529081358?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:02","pubTimestamp":1745236937,"startTime":"0","endTime":"0","summary":"BRIEF-Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related ProposalsApril 21 (Reuters) - Aerovate Therapeutics Inc AVTE.O:AEROVATE THERAPEUTICS STOCKHOLDERS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8QNVVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","AVTE","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2529682808","title":"Aerovate Therapeutics Inc - Stockholders Approve Merger With Jade Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682808","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529682808?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8QNVVW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVTE","JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2529480850","title":"Aerovate Therapeutics Inc - Board Approves 1-for-35 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2529480850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529480850?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8QNVVW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","AVTE","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2526348255","title":"BRIEF-Aerovate Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Jade Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2526348255","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526348255?lang=en_us&edition=fundamental","pubTime":"2025-04-10 04:12","pubTimestamp":1744229522,"startTime":"0","endTime":"0","summary":"BRIEF-Aerovate Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Jade BiosciencesAerovate Therapeutics Inc AVTE.O:AEROVATE THERAPEUTICS DECLARES SPECIAL CASH DIVI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN1AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","AVTE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2526348981","title":"Aerovate Therapeutics Declares Special Cash Dividend in Connection With the Proposed Merger With Jade Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2526348981","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526348981?lang=en_us&edition=fundamental","pubTime":"2025-04-10 04:05","pubTimestamp":1744229115,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN1AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVTE","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2526348601","title":"Aerovate Therapeutics Inc: Cash Dividend Will Be an Aggregate of $69.6 Mln, or an Estimated $2.40 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2526348601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526348601?lang=en_us&edition=fundamental","pubTime":"2025-04-10 04:05","pubTimestamp":1744229115,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN1AI:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVTE","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2525434170","title":"BRIEF-Aerovate Therapeutics Announces Range Of Expected Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2525434170","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525434170?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:08","pubTimestamp":1744031324,"startTime":"0","endTime":"0","summary":"BRIEF-Aerovate Therapeutics Announces Range Of Expected Cash DividendApril 7 (Reuters) - Aerovate Therapeutics Inc AVTE.O:AEROVATE THERAPEUTICS ANNOUNCES RANGE OF EXPECTED CASH DIVIDEND IN CONNECTION ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","AVTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2525102810","title":"Aerovate Therapeutics Inc - Cash Dividend Expected to Be in Range of $67.6 - 69.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2525102810","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525102810?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:30","pubTimestamp":1744029009,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL02Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","AVTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2522305025","title":"Aerovate Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522305025","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522305025?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:16","pubTimestamp":1743081415,"startTime":"0","endTime":"0","summary":"Aerovate Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryAerovate Therapeutics Inc AVTE.OQ reported a quarterly adjusted loss of 19 cents per share for the quarter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA17J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2521925469","title":"Aerovate Therapeutics Inc  expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521925469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521925469?lang=en_us&edition=fundamental","pubTime":"2025-03-22 04:28","pubTimestamp":1742588885,"startTime":"0","endTime":"0","summary":"Aerovate Therapeutics Inc  expected to post a loss of25cents a share - Earnings Preview Aerovate Therapeutics Inc AVTE.OQ AVTE.O is expected to show no change in quarterly revenue when it reports  res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q4225:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aerovatetx.com","stockEarnings":[{"period":"1week","weight":-0.9714},{"period":"1month","weight":-0.9714},{"period":"3month","weight":-0.9714},{"period":"6month","weight":-0.9714},{"period":"1year","weight":-0.9714},{"period":"ytd","weight":-0.9714}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.093905},{"month":2,"riseRate":0.5,"avgChangeRate":0.00635},{"month":3,"riseRate":0.75,"avgChangeRate":0.252318},{"month":4,"riseRate":0.5,"avgChangeRate":-0.130082},{"month":5,"riseRate":0,"avgChangeRate":-0.133359},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.187689},{"month":7,"riseRate":0.75,"avgChangeRate":0.02507},{"month":8,"riseRate":0.5,"avgChangeRate":0.04806},{"month":9,"riseRate":0.5,"avgChangeRate":0.000156},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027466},{"month":11,"riseRate":0.5,"avgChangeRate":0.095112},{"month":12,"riseRate":0.75,"avgChangeRate":0.215812}],"exchange":"NASDAQ","name":"Aerovate Therapeutics, Inc.","nameEN":"Aerovate Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aerovate Therapeutics, Inc.(AVTE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aerovate Therapeutics, Inc.(AVTE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aerovate Therapeutics, Inc.,AVTE,Aerovate Therapeutics, Inc.股票,Aerovate Therapeutics, Inc.股票老虎,Aerovate Therapeutics, Inc.股票老虎国际,Aerovate Therapeutics, Inc.行情,Aerovate Therapeutics, Inc.股票行情,Aerovate Therapeutics, Inc.股价,Aerovate Therapeutics, Inc.股市,Aerovate Therapeutics, Inc.股票价格,Aerovate Therapeutics, Inc.股票交易,Aerovate Therapeutics, Inc.股票购买,Aerovate Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aerovate Therapeutics, Inc.(AVTE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aerovate Therapeutics, Inc.(AVTE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction